PLYGF (PolyPeptide Group AG) YoY EPS Growth: 134.99% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PLYGF PolyPeptide Group AG PLYGF
57 GF Score
Price $54.42
GF Value $31.82
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is PolyPeptide Group AG YoY EPS Growth?

PolyPeptide Group AG PLYGF 57 YoY EPS Growth is 134.99% as of Jun. 2026. GuruFocus rates PLYGF with a GF Score™ of 57/100 and a GF Value™ of $31.82 (Significantly Overvalued). The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. PolyPeptide Group AG's YoY EPS Growth for the quarter that ended in Jun. 2026 was 134.99%.

PolyPeptide Group AG's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was $0.32.

PolyPeptide Group AG YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG YoY EPS Growth Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial 31.20 -84.71 -769.69 63.67 -21.20

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.55 55.73 -144.83 174.50 134.99
PLYGF
57GF Score
PolyPeptide Group AG PLYGF
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

PolyPeptide Group AG's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.749--0.618)/ | -0.618 |
=-21.20 %

PolyPeptide Group AG's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(0.323--0.923)/ | -0.923 |
=134.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 134.99% mean?
PolyPeptide Group AG (PLYGF) has a YoY EPS Growth of 134.99% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's YoY EPS Growth too high?
PolyPeptide Group AG's current YoY EPS Growth is 134.99%. Overall, PolyPeptide Group AG has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's YoY EPS Growth compare to ZTS and UTHR?
PolyPeptide Group AG's YoY EPS Growth of 134.99% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current YoY EPS Growth is 134.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $31.82, compared to a current price of $54.42 — trading 71% above its estimated fair value. The current YoY EPS Growth is 134.99%. PolyPeptide Group AG's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current YoY EPS Growth is 134.99% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $54.42 is trading 71% above its estimated GF Value™ of $31.82. GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.

Key valuation signals for PLYGF:

  • YoY EPS Growth: 134.99%
  • GF Value™: $31.82 vs. price of $54.42 (71% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
57GF Score

Get the complete analysis for PLYGF

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$54.42
Price
$31.82
GF Value